New weekly shot helps shed pounds in chinese obesity trial
NCT ID NCT04904913
First seen Nov 17, 2025 · Last updated Jun 16, 2026 · Updated 36 times
Summary
This study tested a new medicine called IBI362 in 328 overweight or obese adults in China. Participants received weekly injections of different doses of IBI362 or a placebo for 24 weeks, while also following diet and exercise plans. The main goal was to see how much weight they lost. The results showed that IBI362 helped people lose more weight than placebo, with higher doses leading to greater weight loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University people's hospital
Beijing, Beijing Municipality, 100044, China
Conditions
Explore the condition pages connected to this study.